Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Neoplasms 1520Carcinoma, Non-Small-Cell Lung 754Breast Neoplasms 572Neoplasm Metastasis 529Colorectal Neoplasms 445Melanoma 391Leukemia, Myeloid, Acute 371Multiple Myeloma 363Ovarian Neoplasms 352Recurrence 336Lymphoma 334Advanced Solid Tumors 324Lymphoma, Non-Hodgkin 314Prostatic Neoplasms 300Pancreatic Neoplasms 285Advanced Solid Tumor 240Stomach Neoplasms 232Carcinoma, Renal Cell 225Squamous Cell Carcinoma of Head and Neck 210Lung Neoplasms 210Solid Tumor 204Leukemia, Lymphocytic, Chronic, B-Cell 198Triple Negative Breast Neoplasms 183Solid Tumors 182Carcinoma, Hepatocellular 164Hematologic Neoplasms 155Head and Neck Neoplasms 152Lymphoma, Large B-Cell, Diffuse 148Lymphoma, Follicular 146Glioblastoma 145

Interventions

cabazitaxel 1XRP6258 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Solid Cancer × Clear all
NCT07281326 2025-12-15

A Study of AK138D1 in Advanced Malignant Tumors

Akeso

Phase 1 Recruiting
200 enrolled

Solid Cancer

NCT06730386 2025-03-06

A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors

Akeso

Phase 1 Recruiting
100 enrolled

Solid Cancer

NCT06763159 2025-01-08

A Study of HS-20124 in Patients with Advanced Solid Tumors

Hansoh BioMedical R&D Company

Phase 1 Recruiting
450 enrolled

Solid Cancer

NCT00925743 2013-05-16

A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer

Sanofi

Phase 1 Completed
76 enrolled

Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡